Frontlight ResearchEarly access
Kidney cancer trials in United States
210 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 10
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06699602 - Phase 2Taking peopleCemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
- Where
- Oklahoma City
- Age
- 18 years and over
- People
- 72
- Run by
- University of Oklahoma
See details and how to joinNCT07223541 - No phaseNot yet taking people in United StatesTumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
- Where
- Rochester
- People
- 300
- Run by
- Mayo Clinic
See details and how to joinNCT07243067 - Phase 2Taking peopleContrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 210
- Run by
- john eisenbrey
See details and how to joinNCT05641935 - Phase 1Taking peopleImmunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Where
- Seattle
- Age
- 1 year to 26 years
- People
- 21
- Run by
- Seattle Children's Hospital
See details and how to joinNCT07148050 - No phaseTaking peopleAn Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
- Where
- Dallas
- Age
- 18 years and over
- People
- 600
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT04623502 - No phaseTaking peopleAscertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Where
- Basking Ridge, Commack, Harrison, Middletown, New York, Rockville Centre
- People
- 500
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT00582621 - Phase 1Taking peopleA Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- Where
- Boston, Denver, Fairfax, Grand Rapids, Houston, Miami Beach, Nashville, New Haven, New York, Oklahoma City, San Antonio, Sarasota
- Age
- 18 years and over
- People
- 263 worldwide
- Run by
- OnCusp Therapeutics, Inc.
See details and how to joinNCT06234423 · EU 2024-519862-33-01 - Phase 1/2Taking peopleRetifanlimab and Ruxolitinib In Solid Malignancies
- Where
- La Jolla
- People
- 40
- Run by
- University of California, San Diego
See details and how to joinNCT07219576 - No phaseEnrolling by invitationHead-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
- Where
- Boston
- People
- 30
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07307157 - No phaseTaking peopleIntra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 30
- Run by
- Palo Alto Veterans Institute for Research
See details and how to joinNCT07303725 - No phaseTaking peopleDesigning Visual Tools to Enhance Cancer Surgeon Decision-making
- Where
- Chapel Hill, Wilmington
- Age
- 18 years and over
- People
- 220
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06965192 - Phase 2Taking peopleTrial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
- Where
- New Haven
- Age
- 18 years and over
- People
- 30
- Run by
- Yale University
See details and how to joinNCT04974671 - Phase 1Taking people[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
- Where
- Dallas
- Age
- 18 years and over
- People
- 35
- Run by
- Orhan Kemal Oz
See details and how to joinNCT04989959 - No phaseTaking peopleDecision Aid (DA) for Renal Patients
- Where
- New York
- Age
- 18 years and over
- People
- 40
- Run by
- NYU Langone Health
See details and how to joinNCT05387863 - Phase 1Taking peopleStudy to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
- Where
- Fairfax
- Age
- 18 years and over
- People
- 76
- Run by
- LG Chem
See details and how to joinNCT06332755 - No phaseTaking peopleStereotactic Magnetic Resonance Guided Radiation Therapy
- Where
- Boston
- Age
- 18 years and over
- People
- 397
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04115254 - Phase 1Taking peopleImmunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Where
- Houston
- Age
- Up to 21 years
- People
- 21
- Run by
- Baylor College of Medicine
See details and how to joinNCT06198296 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Where
- Columbus, Gilbert, Jacksonville, La Jolla, Los Angeles, New York, Rochester, Seattle, St Louis, Tampa
- Age
- 18 years and over
- People
- 240
- Run by
- A2 Biotherapeutics Inc.
See details and how to joinNCT06682793 - Phase 2Taking peopleA Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Where
- Aurora, Birmingham, Columbus, Salt Lake City, The Bronx, Washington D.C.
- Age
- 18 months to 40 years
- People
- 86
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05135975 - No phaseEnrolling by invitationClinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
- Where
- New York, Washington D.C.
- Age
- 18 years and over
- People
- 104
- Run by
- MediView XR, Inc.
See details and how to joinNCT07046832 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Boston, Chapel Hill, Hershey, Los Angeles, Madison, Tampa
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - Phase 4Taking peoplePreop Laxatives in Robotic Urologic Surgery
- Where
- Iowa City
- Age
- 30 years to 100 years
- People
- 240
- Run by
- Chad R. Tracy
See details and how to joinNCT05805436 - Phase 3CompletedA Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- Where
- Easton, Kettering, Lake Success, Louisville, New Orleans, Omaha, Phoenix, Portland, Rochester, Sacramento, San Francisco, Spokane, Tyler
- Age
- 18 years and over
- People
- 413 worldwide
- Run by
- Xynomic Pharmaceuticals, Inc.
See details and how to joinNCT03592472